SCHEMBL10487443

SCHEMBL10487443

CCOC(=O)[C@@H](C)Oc1ccc(Cl)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
L3MBTL1 Q9Y468 3/20 0.54
LMNA P02545 1/20 0.54
EPHX2 P34913 2/20 0.50
GAA P10253 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
TSHR P16473 1/20 0.47
FFAR1 O14842 1/20 0.46
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
MEN1 O00255 2/20 0.44
PKM P14618 1/20 0.44
ALDH2 P05091 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10712640 0.93 L3MBTL1 (0.51) KMT2AL3MBTL1LMNAEPHX2GAA
SCHEMBL13744595 0.89 KMT2A (0.53) KMT2AL3MBTL1LMNAEPHX2GAA
SCHEMBL10714951 0.86 KMT2A (0.51) KMT2AL3MBTL1LMNAEPHX2GAA
SCHEMBL10487407 0.86 KMT2A (0.51) KMT2AL3MBTL1LMNAEPHX2GAA
SCHEMBL10022852 0.83 EPHX2 (0.66) KMT2AL3MBTL1LMNAEPHX2GAA
SCHEMBL5204883 0.83 EPHX2 (0.66) KMT2AL3MBTL1LMNAEPHX2GAA
SCHEMBL28285419 0.83 AR (0.53) KMT2ALMNASMN1; SMN2TSHRFFAR1
SCHEMBL5711747 0.81 ALDH1A1 (0.47) KMT2ALMNASMN1; SMN2TSHRFFAR1
SCHEMBL28914011 0.81 SMN1; SMN2 (0.48) KMT2AL3MBTL1LMNAEPHX2TDP1
SCHEMBL5209931 0.80 TDP1 (0.67) KMT2AL3MBTL1LMNAEPHX2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4853410-A Hydroxyacetic acid derivatives for the treatment of diabetic complications PFIZER INC. (US) 1989-08-01 US disclosed
EP-0230379-A2 Chroman- and thiochroman-4-acetic acids useful in the treatment of diabetic complications PFIZER INC. (US) 1987-07-29 EP disclosed